Novo Nordisk's third-quarter sales were 74.98 billion Danish kroner, estimated at 76.68 billion Danish kroner.

```

Novo Nordisk's third-quarter sales were 74.98 billion Danish kroner, with an estimate of 76.68 billion Danish kroner.

Risk Warning and DisclaimerThe market has risks, and investment should be made cautiously. This article does not constitute personal investment advice, nor does it take into account the special investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their particular circumstances. Any investment based on this is at your own risk. ```